3.26.1 html 510 409 1 false 123 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.nrxpharma.com/20260630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-statements-of-changes-in-stockholders-deficit-unaudited Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) (Parentheticals) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-statements-of-changes-in-stockholders-deficit-unaudited-parentheticals Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.nrxpharma.com/20260630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Business and Organization Sheet http://www.nrxpharma.com/20260630/role/statement-note-1-business-and-organization Note 1 - Business and Organization Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Significant Accounting Policies Sheet http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies Note 2 - Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Revenue and Accounts Receivable Sheet http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable Note 3 - Revenue and Accounts Receivable Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Prepaid Expense and Other Current Assets Sheet http://www.nrxpharma.com/20260630/role/statement-note-4-prepaid-expense-and-other-current-assets Note 4 - Prepaid Expense and Other Current Assets Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Property and Equipment, Net Sheet http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net Note 5 - Property and Equipment, Net Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Leases Sheet http://www.nrxpharma.com/20260630/role/statement-note-6-leases Note 6 - Leases Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Accrued and Other Current Liabilities Sheet http://www.nrxpharma.com/20260630/role/statement-note-7-accrued-and-other-current-liabilities Note 7 - Accrued and Other Current Liabilities Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Alvogen Licensing Agreement Sheet http://www.nrxpharma.com/20260630/role/statement-note-8-alvogen-licensing-agreement- Note 8 - Alvogen Licensing Agreement Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Debt Sheet http://www.nrxpharma.com/20260630/role/statement-note-9-debt Note 9 - Debt Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Equity Sheet http://www.nrxpharma.com/20260630/role/statement-note-11-equity Note 11 - Equity Notes 18 false false R19.htm 018 - Disclosure - Note 12 - Stock-based Compensation Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation Note 12 - Stock-based Compensation Notes 19 false false R20.htm 019 - Disclosure - Note 13 - Fair Value Measurements Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements Note 13 - Fair Value Measurements Notes 20 false false R21.htm 020 - Disclosure - Note 14 - Segment Reporting Sheet http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting Note 14 - Segment Reporting Notes 21 false false R22.htm 021 - Disclosure - Note 15 - Income Taxes Sheet http://www.nrxpharma.com/20260630/role/statement-note-15-income-taxes Note 15 - Income Taxes Notes 22 false false R23.htm 022 - Disclosure - Note 16 - Business Acquisition Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition Note 16 - Business Acquisition Notes 23 false false R24.htm 023 - Disclosure - Note 17 - Related Party Transactions Sheet http://www.nrxpharma.com/20260630/role/statement-note-17-related-party-transactions Note 17 - Related Party Transactions Notes 24 false false R25.htm 024 - Disclosure - Note 18 - Investment in Cohen and Associates Sheet http://www.nrxpharma.com/20260630/role/statement-note-18-investment-in-cohen-and-associates Note 18 - Investment in Cohen and Associates Notes 25 false false R26.htm 025 - Disclosure - Note 19 - Subsequent Events Sheet http://www.nrxpharma.com/20260630/role/statement-note-19-subsequent-events Note 19 - Subsequent Events Notes 26 false false R27.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 27 false false R28.htm 995472 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.nrxpharma.com/20260630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies 28 false false R29.htm 995473 - Disclosure - Note 2 - Significant Accounting Policies (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies-tables Note 2 - Significant Accounting Policies (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies 29 false false R30.htm 995474 - Disclosure - Note 3 - Revenue and Accounts Receivable (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable-tables Note 3 - Revenue and Accounts Receivable (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable 30 false false R31.htm 995475 - Disclosure - Note 4 - Prepaid Expense and Other Current Assets (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-4-prepaid-expense-and-other-current-assets-tables Note 4 - Prepaid Expense and Other Current Assets (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-4-prepaid-expense-and-other-current-assets 31 false false R32.htm 995476 - Disclosure - Note 5 - Property and Equipment, Net (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net-tables Note 5 - Property and Equipment, Net (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net 32 false false R33.htm 995477 - Disclosure - Note 6 - Leases (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-6-leases-tables Note 6 - Leases (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-6-leases 33 false false R34.htm 995478 - Disclosure - Note 7 - Accrued and Other Current Liabilities (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-7-accrued-and-other-current-liabilities-tables Note 7 - Accrued and Other Current Liabilities (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-7-accrued-and-other-current-liabilities 34 false false R35.htm 995479 - Disclosure - Note 9 - Debt (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-9-debt-tables Note 9 - Debt (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-9-debt 35 false false R36.htm 995480 - Disclosure - Note 10 - Commitments and Contingencies (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies-tables Note 10 - Commitments and Contingencies (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies 36 false false R37.htm 995481 - Disclosure - Note 11 - Equity (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-11-equity-tables Note 11 - Equity (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-11-equity 37 false false R38.htm 995482 - Disclosure - Note 12 - Stock-based Compensation (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-tables Note 12 - Stock-based Compensation (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation 38 false false R39.htm 995483 - Disclosure - Note 13 - Fair Value Measurements (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-tables Note 13 - Fair Value Measurements (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements 39 false false R40.htm 995484 - Disclosure - Note 14 - Segment Reporting (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting-tables Note 14 - Segment Reporting (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting 40 false false R41.htm 995485 - Disclosure - Note 16 - Business Acquisition (Tables) Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-tables Note 16 - Business Acquisition (Tables) Tables http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition 41 false false R42.htm 995486 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies-details-textual Note 2 - Significant Accounting Policies (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies-tables 42 false false R43.htm 995487 - Disclosure - Note 2 - Significant Accounting Policies - Schedule of Antidilutive Securities (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-2-significant-accounting-policies-schedule-of-antidilutive-securities-details Note 2 - Significant Accounting Policies - Schedule of Antidilutive Securities (Details) Details 43 false false R44.htm 995488 - Disclosure - Note 3 - Revenue and Accounts Receivable - Disaggregation of Revenue (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable-disaggregation-of-revenue-details Note 3 - Revenue and Accounts Receivable - Disaggregation of Revenue (Details) Details 44 false false R45.htm 995489 - Disclosure - Note 3 - Revenue and Accounts Receivable - Schedule of Accounts Receivable (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable-schedule-of-accounts-receivable-details Note 3 - Revenue and Accounts Receivable - Schedule of Accounts Receivable (Details) Details 45 false false R46.htm 995490 - Disclosure - Note 3 - Revenue and Accounts Receivable - Allowance for Credit Loss (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-3-revenue-and-accounts-receivable-allowance-for-credit-loss-details Note 3 - Revenue and Accounts Receivable - Allowance for Credit Loss (Details) Details 46 false false R47.htm 995491 - Disclosure - Note 4 - Prepaid Expense and Other Current Assets - Schedule of Prepaid Expense and Other Current Assets (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-4-prepaid-expense-and-other-current-assets-schedule-of-prepaid-expense-and-other-current-assets-details Note 4 - Prepaid Expense and Other Current Assets - Schedule of Prepaid Expense and Other Current Assets (Details) Details 47 false false R48.htm 995492 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net-details-textual Note 5 - Property and Equipment, Net (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net-tables 48 false false R49.htm 995493 - Disclosure - Note 5 - Property and Equipment, Net - Furniture and Equipment (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-5-property-and-equipment-net-furniture-and-equipment-details Note 5 - Property and Equipment, Net - Furniture and Equipment (Details) Details 49 false false R50.htm 995494 - Disclosure - Note 6 - Leases (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-6-leases-details-textual Note 6 - Leases (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-6-leases-tables 50 false false R51.htm 995495 - Disclosure - Note 6 - Leases - Components of Lease Expense (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-6-leases-components-of-lease-expense-details Note 6 - Leases - Components of Lease Expense (Details) Details 51 false false R52.htm 995496 - Disclosure - Note 6 - Leases - Schedule of Minimum Lease Payments (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-6-leases-schedule-of-minimum-lease-payments-details Note 6 - Leases - Schedule of Minimum Lease Payments (Details) Details 52 false false R53.htm 995497 - Disclosure - Note 7 - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-7-accrued-and-other-current-liabilities-schedule-of-accrued-and-other-current-liabilities-details Note 7 - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Details 53 false false R54.htm 995498 - Disclosure - Note 8 - Alvogen Licensing Agreement (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-8-alvogen-licensing-agreement-details-textual Note 8 - Alvogen Licensing Agreement (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-8-alvogen-licensing-agreement- 54 false false R55.htm 995499 - Disclosure - Note 9 - Debt (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-9-debt-details-textual Note 9 - Debt (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-9-debt-tables 55 false false R56.htm 995500 - Disclosure - Note 9 - Debt - Schedule of Debt (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-9-debt-schedule-of-debt-details Note 9 - Debt - Schedule of Debt (Details) Details 56 false false R57.htm 995501 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies-details-textual Note 10 - Commitments and Contingencies (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies-tables 57 false false R58.htm 995502 - Disclosure - Note 10 - Commitments and Contingencies - Schedule of Milestone Payments (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-10-commitments-and-contingencies-schedule-of-milestone-payments-details Note 10 - Commitments and Contingencies - Schedule of Milestone Payments (Details) Details 58 false false R59.htm 995503 - Disclosure - Note 11 - Equity (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-11-equity-details-textual Note 11 - Equity (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-11-equity-tables 59 false false R60.htm 995504 - Disclosure - Note 11 - Equity - Schedule of Warrants (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-11-equity-schedule-of-warrants-details Note 11 - Equity - Schedule of Warrants (Details) Details 60 false false R61.htm 995505 - Disclosure - Note 12 - Stock-based Compensation (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-details-textual Note 12 - Stock-based Compensation (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-tables 61 false false R62.htm 995506 - Disclosure - Note 12 - Stock-based Compensation - Schedule of Stock Options (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-schedule-of-stock-options-details Note 12 - Stock-based Compensation - Schedule of Stock Options (Details) Details 62 false false R63.htm 995507 - Disclosure - Note 12 - Stock-based Compensation - Schedule of Restricted Stock Awards (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-schedule-of-restricted-stock-awards-details Note 12 - Stock-based Compensation - Schedule of Restricted Stock Awards (Details) Details 63 false false R64.htm 995508 - Disclosure - Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-schedule-of-stockbased-compensation-details Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation (Details) Details 64 false false R65.htm 995509 - Disclosure - Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation 2 (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-12-stockbased-compensation-schedule-of-stockbased-compensation-2-details Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation 2 (Details) Details 65 false false R66.htm 995510 - Disclosure - Note 13 - Fair Value Measurements (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-details-textual Note 13 - Fair Value Measurements (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-tables 66 false false R67.htm 995511 - Disclosure - Note 13 - Fair Value Measurements - Schedule of Assets and Liabilities on A Recurring Basis (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-schedule-of-assets-and-liabilities-on-a-recurring-basis-details Note 13 - Fair Value Measurements - Schedule of Assets and Liabilities on A Recurring Basis (Details) Details 67 false false R68.htm 995512 - Disclosure - Note 13 - Fair Value Measurements - Schedule of Significant Inputs (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-schedule-of-significant-inputs-details Note 13 - Fair Value Measurements - Schedule of Significant Inputs (Details) Details 68 false false R69.htm 995513 - Disclosure - Note 13 - Fair Value Measurements - Schedule of Recurring Level 3 Fair Value Changes (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-13-fair-value-measurements-schedule-of-recurring-level-3-fair-value-changes-details Note 13 - Fair Value Measurements - Schedule of Recurring Level 3 Fair Value Changes (Details) Details 69 false false R70.htm 995514 - Disclosure - Note 14 - Segment Reporting (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting-details-textual Note 14 - Segment Reporting (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting-tables 70 false false R71.htm 995515 - Disclosure - Note 14 - Segment Reporting - Reconciliation of Loss From Operations to Total Loss (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting-reconciliation-of-loss-from-operations-to-total-loss-details Note 14 - Segment Reporting - Reconciliation of Loss From Operations to Total Loss (Details) Details 71 false false R72.htm 995516 - Disclosure - Note 14 - Segment Reporting - Long-lived Assets (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-14-segment-reporting-longlived-assets-details Note 14 - Segment Reporting - Long-lived Assets (Details) Details 72 false false R73.htm 995517 - Disclosure - Note 15 - Income Taxes (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-15-income-taxes-details-textual Note 15 - Income Taxes (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-15-income-taxes 73 false false R74.htm 995518 - Disclosure - Note 16 - Business Acquisition (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-details-textual Note 16 - Business Acquisition (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-tables 74 false false R75.htm 995519 - Disclosure - Note 16 - Business Acquisition - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-assets-acquired-and-liabilities-assumed-details Note 16 - Business Acquisition - Assets Acquired and Liabilities Assumed (Details) Details 75 false false R76.htm 995520 - Disclosure - Note 16 - Business Acquisition - Acquired Intangible Assets (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-acquired-intangible-assets-details Note 16 - Business Acquisition - Acquired Intangible Assets (Details) Details 76 false false R77.htm 995521 - Disclosure - Note 16 - Business Acquisition - Pro Forma (Details) Sheet http://www.nrxpharma.com/20260630/role/statement-note-16-business-acquisition-pro-forma-details Note 16 - Business Acquisition - Pro Forma (Details) Details 77 false false R78.htm 995522 - Disclosure - Note 17 - Related Party Transactions (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-17-related-party-transactions-details-textual Note 17 - Related Party Transactions (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-17-related-party-transactions 78 false false R79.htm 995523 - Disclosure - Note 18 - Investment in Cohen and Associates (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-18-investment-in-cohen-and-associates-details-textual Note 18 - Investment in Cohen and Associates (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-18-investment-in-cohen-and-associates 79 false false R80.htm 995524 - Disclosure - Note 19 - Subsequent Events (Details Textual) Sheet http://www.nrxpharma.com/20260630/role/statement-note-19-subsequent-events-details-textual Note 19 - Subsequent Events (Details Textual) Details http://www.nrxpharma.com/20260630/role/statement-note-19-subsequent-events 80 false false All Reports Book All Reports nrxp-20260630.xsd nrxp-20260630_cal.xml nrxp-20260630_def.xml nrxp-20260630_lab.xml nrxp-20260630_pre.xml nrxp20260630_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true